Finding Description
9. R22's Order Summary Report dated 09/04/24 documents R22 has diagnoses which include Unspecified Dementia, Unspecified Severity with other behavioral disturbance, Bipolar Disorder, Major Depressive Disorder and Delusional Disorders.
R22's Order Summary Report documents an order for Quetiapine Fumarate 25 milligrams by mouth two times daily.
R22's Care plan last reviewed 08/12/24 documents R22 has been verbally aggressive towards staff related to dementia. R2 is/has potential to be physically aggressive towards staff related to dementia, R22 is resistive to care, refuses medications related to dementia. R22 has impaired cognitive function/dementia or impaired thought processes related to dementia, cerebrovascular accident.
R22's Behavior Tracking Report documents R22 had four behaviors between 03/01/24 and 06/30/24 which include: 03/23/24 Mood Changes, 03/24/24 Compulsive, 04/26/24 Uncooperative, and 06/07/24 Uncooperative.
On 09/03/24 at 10:53 AM, R22 was in her wheelchair near the dining room. R22 appeared calm while sitting and watching other people.
On 09/03/24 at 1:10 PM, R22 was sitting in her wheelchair in her room. R22 was alert, confused and appeared calm.
On 09/04/22 at 11:10 AM, R22 was in the hallway speaking with staff. R22 appeared calm and was asking about lunch time.
On 09/06/22 at 11:32 AM, R22 was receiving cares. R22 was alert, confused and appeared to be in a pleasant mood while interacting with staff.
On 09/06/22 at 11:32 AM, V5/CNA and V6/CNA stated they were not aware of R22 having behaviors. V5 stated R22 was a real nice lady.
On 09/06/24 at 10:33 AM, V1 verified the facility Behavior Tracking Tool (undated) did not list R22 as having any behaviors between 07/03/24 and 09/03/24.
Based on observation, interview, and record review the facility failed to provide an appropriate indication for use of antipsychotic medications in seven residents (R22, R39, R70, R81, R102, R214, R415) with diagnosis of Dementia and failed to identify non-pharmacological interventions for two residents (R9, R110) receiving antidepressant medications of nine residents reviewed for unnecessary psychotropic medications in the sample of 59.
Findings include:
Facility Policy/Psychotropic Medications dated/revised 1/2024 documents:
Residents will only be given antipsychotic drugs when clinically indicated according to appropriate diagnosis and physician's order.
Duplicate Drug Therapy: Any drug therapy that duplicates a particular drug effect on the resident without any demonstrative therapeutic benefit. Any two or more drugs, whether from the same category or not, that have a sedative effect.
Antipsychotic Drug: A neuroleptic drug that is helpful in the treatment of psychosis and has a capacity to ameliorate thought disorders.
Psychotropic medications shall be used only after alternative methods have been tried unsuccessfully and only upon the written order of a physician and after informed consent has been received from the resident/representative.
The resident's care plan will include objectives for gradual dose reduction as well as alternative interventions to assist in gradual dose reduction.
1) Current Physician Order Summary Report indicates R39 has orders for Risperdal (antipsychotic) 0.25mg (milligrams) at bedtime related to Unspecified Dementia with Anxiety (order date 7/18/24).
R39's medical record indicates R39 has diagnoses of Dementia with Other Behavioral Disturbance and Anxiety with start date of 1/11/24.
Consent for Psychotropic Medications indicates consent was given on 7/18/24 to receive Risperdal for Dementia with behaviors.
Psychiatry Note dated 1/25/24 indicates Start Risperdal 0.5mg twice daily due to exhibits Dementia behaviors including physical and verbal aggression, refusal of care including refusal to get out of bed. Note indicates no audio/visual hallucinations, no symptoms of psychosis.
R39's Care Plan indicates (R39) receives an antipsychotic medication related to Dementia without behavioral disturbance. R39's Care Plan also indicates R39's behaviors related to Dementia are yelling out and arguing with staff, looking for her grandson; has potential to be physically aggressive with staff related to Dementia.
On 9/3/24, 9/4/24 and 9/6/24 R39 was seen in the memory care unit participating in activities during lunch meals.
On 9/6/24 at 11:35am V12, Memory Care Unit Director stated R39's only behaviors are being resistive to care at times and putting herself on the floor.
2) R70's medical record indicates R70 has diagnoses of Dementia, Moderate with Mood Disturbance dated 10/1/23 and Alzheimer's Disease dated 8/1/23.
R70's Current Physician Order Summary Report indicates R70 has orders for Olanzapine (antipsychotic)2.5mg twice daily for Dementia with Mood Disorder (date ordered 5/22/24).
Consent for Psychotropic Medications indicates consent was given on 5/20/24 via telephone for R70 to receive Olanzapine. Consent does not include indication for use, diagnosis, or target behaviors.
Psychiatry Note dated 8/8/24 indicates R70 continues to have sundowning behaviors almost daily, with behaviors starting around 4pm and sometimes continuing until 10pm.
Note indicates no audio/visual hallucinations, no symptoms of psychosis or mania. Note indicates We will shift her Olanzapine today in hopes to better target her Dementia related behaviors and agitation. Note also indicates R70 receives the following psychotropic medications: Escitalopram and Mirtazapine (antidepressants) for Depression Melatonin for Insomnia, Depakote (Mood Stabilizer) for Mood.
Current Care Plan indicates R70 receives antipsychotic medications related to Bipolar Disorder dated/revised 8/31/22. Care Plan indicates R70's behaviors are related to Dementia - packing belongings and going home, looking for a baby, interferes with other resident's care, looking for her sister and Physically aggressive to staff related to Dementia.
On 9/3/24, 9/4/24 and 9/6/24 R70 was seen in the memory care unit participating in activities during lunch meals.
On 9/3/24 and 9/6/24 V13, R70's Spouse stated he visits R70 every day and most of R70's behaviors are after he leaves for the day and R70 wants to go home.
Behavior tracking 8/6/24 to 9/4/24 indicate R70's behaviors do not occur every day and are episodic.
3) Current Physician Order Summary Report indicates R81 has orders for Olanzapine (antipsychotic) 10mg in the evening and 5mg daily related to Bipolar Disorder (date ordered 5/10/24).
Report also indicates R81 receives Haldol (antipsychotic) Decanoate injection 25mg weekly for Bipolar (order date 5/10/24).
R81's medical record indicates R81 has the following diagnoses: Dementia with other Behavioral Disturbance 12/9/22 (admit), Unspecified Psychosis 12/9/22. Bipolar 12/12/22 and
Bipolar Hypomanic 5/12/23
Consent for Psychotropic Medication(s) dated 5/10/24 indicates consent was received for R81 to receive Haldol 25mg weekly and on 5/2/24 for R81 to receive Olanzapine 10mg at bedtime and 5mg daily for Bipolar Disorder.
Psychiatry Note dated 8/13/24 indicates R81 is now receiving Hospice Care, does continue to wander the halls, but has not been overly intrusive. Note indicates no symptoms of psychosis or mania.
R81's Care Plan indicates R81 receives antipsychotic medication related to Bipolar. Care Plan indicates R81's behaviors are related to Dementia - refuses labs, wanders, resisting care and aggressive with staff; hovers over residents while they eat, removes utensils from their hands; refuses medications, refuses to eat. and is verbally aggressive with staff related to Dementia.
Care Plan does not identify behaviors related to Bipolar Disorder.
On 9/3/24, 9/4/24 and 9/6/24 R81 was seen in the memory care unit either sleeping in her bed or wandering the halls.
On 9/6/24 at 11:40am V12, Memory Care Director stated that R81's behaviors are mainly pacing (R81) is unable to actively participate in activities.
4) R102's Medical Record indicates R102 has the following diagnoses:
Dementia without Behavioral Disturbance, Mood or Anxiety dated 4/23/24 (admit) and
Disorganized Schizophrenia 4/23/24.
Current Physicians Order Summary Report indicates R102 receives Seroquel (antipsychotic) 50mg at bedtime for Disorganized Schizophrenia (date ordered 7/4/24).
Psychiatry Note dated 7/25/24 indicates on that date R102 was pleasant and in good spirits. Note indicates R102 continues to respond to internal stimuli but does so quietly and pleasantly. Note indicates there is no evidence of auditory nor visual hallucinations and no symptoms of psychosis or mania. No substance cravings for nicotine dependence.
R102's Care Plan indicates R102 receives antipsychotic medication related to Disorganized Schizophrenia (revised 5/23/24) and that R102 has a behavior problem related to Disorganized Schizophrenia - has a habit of refusing showers when out of cigarettes.
No other behaviors of Dementia or Schizophrenia were identified in R102's care plan.
Consent for Psychotropic Medication(s) dated 7/4/24 indicates consent was given on that date to increase R102's Seroquel from 25mg to 50mg at bedtime. Consent does not indicate reason for increase, diagnoses, or target behaviors.
No progress notes were found or presented documenting the reason or justification for Seroquel ordered/increased on 7/4/24.
On 9/3/24, 9/4/24 and 9/6/24 R81 was seen in the memory care unit in activities and during meals.
On 9/6/24 at 11:40am V12, Memory Care Director stated that R102's behaviors are refusing showers when can't have a cigarette. I don't know of any other behaviors that (R102) has.
5) R214's Medical Record indicates R214 has the following diagnoses:
Admitting Diagnosis: Dementia with Agitation/Psychotic Disturbance 8/20/24
Secondary Diagnosis: Bipolar Disorder 8/20/24
Current Physician Order Summary Report indicates R214 receives Haldol (antipsychotic) Injection 5mg every 8 hours as needed for agitation X 14 days (date ordered 8/29/24);
Olanzapine (antipsychotic) 5mg daily for Bipolar Disorder date ordered 8/29/24;
Quetiapine (antipsychotic) 50mg twice daily related to Bipolar Disorder date ordered 8/28/24
Psychiatry Note dated 8/22/24 indicates R214 is a new admit, combative, resisting care, hits, kicks, and fights. Note indicates R214 does not experience any psychotic symptoms, including auditory or visual hallucinations, no mania. Note indicates R214 has an underlying neurocognitive disorder that could be exacerbated by current medication regimen. Note indicates author of note recommends to add Olanzapine (as needed).
Current Care Plan indicates R214 has Behavior of Resisting Cares and verbally and physically aggressive with staff related to Dementia, stands up from wheelchair without assist, makes inappropriate comments to staff - dated initiated 8/21/24/revised 8/28/24.
No progress notes indicating circumstances/necessity of ordering multiple psychotropic medications for R214 including duplicate antipsychotic therapy were found or presented.
No care plan was found or presented for any of R214's psychotropic/antipsychotic medications.
On 9/3/24, 9/4/24 and 9/6/24 R214 was seen in the memory care unit in during meals and in her room with her spouse.
On 9/4/24 at 10:30am V14, Spouse stated that R214 is confused and is resistive to care. V14 stated he was informed of the need for the (psychotropic) medications due to R214's behaviors. V14 stated he stays with R214 every day until about 630pm.
On 9/6/24 at 11:50am V1, Administrator stated I agree there seems to be a lack of justification for these medications. We need to do better with this.
8. R415's Physician Order Sheet dated September 2024 list diagnoses of disorientation, claustrophobia, unspecified dementia without behavioral disturbance, psychotic disturbance, anxiety disorder and panic disorder.
R415's Physician Order Sheet dated September 2024 documents that R415 was started on Quetiapine Fumarate, an antipsychotic medication, for depression on 9/3/24.
On 9/6/24 at 11:30AM V2 (Director of Nursing) stated An antipsychotic shouldn't have been ordered for depression. I need to educate our providers. (R145's) behaviors all seem to stem from her dementia and her anxiety.
6. R9's medical record documents R9 has the following diagnoses: Depression and Paranoid Schizophrenia.
R9's Physician Orders for September 2024 documents the following: Fluoxetine HCl/Hydrochloride Oral Capsule 20 MG (Fluoxetine HCl) Give 2 capsule by mouth in the morning for depression related to Depression Unspecified; Quetiapine Fumarate Oral Tablet 300 MG (Quetiapine Fumarate) Give 350 mg by mouth at bedtime for schizophrenia related to Paranoid Schizophrenia; and Olanzapine Oral Tablet 10 MG (Olanzapine) Give 1 tablet by mouth at bedtime related to Paranoid Schizophrenia.
R9's medical record has no documentation of nonpharmacological interventions and no identified indicators/behaviors for use for the above medications.
On 9/6/24 at 12:02PM, V2 DON/Director of Nursing verified there were no nonpharmacological interventions and no identified indicators/behaviors for use for R9 and there should be.
7. R110's medical record documents R110 has the following diagnoses: Anxiety and Depression.
R110's Physician Orders for September 2024 documents the following: Escitalopram Oxalate Oral Tablet 5 MG (Escitalopram Oxalate) Give 1 tablet by mouth in the morning for depression; Trazodone HCl Oral Tablet 100 MG (Trazodone HCl) Give 1 tablet by mouth at bedtime for depression; and Lorazepam Oral Tablet 0.5 MG (Lorazepam) Give 1 tablet by mouth three times a day related to Anxiety Disorder.
R110's medical record has no documentation of nonpharmacological interventions and no identified indicators/behaviors for use for the above medications.
On 9/6/24 at 12:02PM, V2 DON verified there were no nonpharmacological interventions and no identified indicators/behaviors for use for R110 and there should be.